215 related articles for article (PubMed ID: 6400038)
1. Human monoclonal antibodies: methods of production and some aspects of their application in oncology.
Olsson L
Med Oncol Tumor Pharmacother; 1984; 1(4):235-46. PubMed ID: 6400038
[TBL] [Abstract][Full Text] [Related]
2. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
3. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
4. In vitro B-lymphocyte antigen priming against both non-immunogenic and immunogenic molecules requiring low amounts of antigen and applicable in hybridoma technology.
Brams P; Pettijohn DE; Brown M; Olsson L
J Immunol Methods; 1987 Apr; 98(1):11-22. PubMed ID: 2435806
[TBL] [Abstract][Full Text] [Related]
5. Human--human hybridomas secreting lipid A reactive monoclonal antibodies.
Ramachandra RN; Berczi I; Sehon AH
Immunol Lett; 1988 Jun; 18(2):93-7. PubMed ID: 2456987
[TBL] [Abstract][Full Text] [Related]
6. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.
Buchacher A; Predl R; Strutzenberger K; Steinfellner W; Trkola A; Purtscher M; Gruber G; Tauer C; Steindl F; Jungbauer A
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):359-69. PubMed ID: 7520721
[TBL] [Abstract][Full Text] [Related]
7. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
[TBL] [Abstract][Full Text] [Related]
8. [Monoclonal antibodies produced by human-human hybridomas].
Chida J
Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
[TBL] [Abstract][Full Text] [Related]
9. [A strategy for the production of human monoclonal antibodies].
Chiba J
Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
[TBL] [Abstract][Full Text] [Related]
10. Human antibodies for immunotherapy development generated via a human B cell hybridoma technology.
Li J; Sai T; Berger M; Chao Q; Davidson D; Deshmukh G; Drozdowski B; Ebel W; Harley S; Henry M; Jacob S; Kline B; Lazo E; Rotella F; Routhier E; Rudolph K; Sage J; Simon P; Yao J; Zhou Y; Kavuru M; Bonfield T; Thomassen MJ; Sass PM; Nicolaides NC; Grasso L
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3557-62. PubMed ID: 16505368
[TBL] [Abstract][Full Text] [Related]
11. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S
Year Immunol; 1993; 7():213-9. PubMed ID: 8396821
[No Abstract] [Full Text] [Related]
12. Generation of human monoclonal antibodies by fusion of EBV-activated B cells to a human-mouse hybridoma.
Foung SK; Engleman EG; Grumet FC
Methods Enzymol; 1986; 121():168-74. PubMed ID: 3014266
[No Abstract] [Full Text] [Related]
13. The use of Epstein-Barr virus transformation for the production of human monoclonal antibodies.
Roome AJ; Reading CL
Exp Biol; 1984; 43(1):35-55. PubMed ID: 6099808
[TBL] [Abstract][Full Text] [Related]
14. Antibody producing human-human hybridomas. I. Technical aspects.
Olsson L; Kronstrøm H; Cambon-De Mouzon A; Honsik C; Brodin T; Jakobsen B
J Immunol Methods; 1983 Jun; 61(1):17-32. PubMed ID: 6343505
[TBL] [Abstract][Full Text] [Related]
15. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Falcone G
Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
[TBL] [Abstract][Full Text] [Related]
16. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
[TBL] [Abstract][Full Text] [Related]
17. [Preparation of human monoclonal antibodies reactive with human melanoma and the possibility of clinical application].
Yamaguchi H
Gan To Kagaku Ryoho; 1988 May; 15(5):1677-84. PubMed ID: 2835935
[TBL] [Abstract][Full Text] [Related]
18. [Human monoclonal antibodies with human-mouse hybridomas].
Naoe T; Kato K; Shiku H; Yamada K
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2575-81. PubMed ID: 6606396
[TBL] [Abstract][Full Text] [Related]
19. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
20. In vitro stimulation prior to fusion generates antigen-binding human-human hybridomas.
Wasserman RL; Budens RD; Thaxton ES
J Immunol Methods; 1986 Nov; 93(2):275-83. PubMed ID: 3534099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
